Prevention of Herpes Simplex Virus Induced Stromal Keratitis by a Glycoprotein B-Specific Monoclonal Antibody
Adalbert Krawczyk(Essen University Hospital), Dirk Bauer(St. Franziskus Hospital)
Cited by 29
Related Papers
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2017|249
Superior antiviral activity of IFNβ in genital HSV-1 infection
|Frontiers in Cellular and Infection Microbiology|2022|7